Skip to main content

Sinovac Biotech Ltd

SVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001084201

No open-market purchases or sales by Sinovac Biotech Ltd insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Sinovac Biotech Ltd changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of SVA: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders1131+20
Shares6.39M11.8M+5.40M (+84.5%)
Value$41.6M$44.0M+$2.39M (+5.7%)

New holders (21)

Institutions that held Sinovac Biotech Ltd at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to SVA in Q2 2022
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC2,375,841$1.54M0.00%
State Street Corp160,875$1.04M0.00%
Skandinaviska Enskilda Banken AB (publ)40,000$259.0K0.00%
Geode Capital Management, LLC27,717$179.0K0.00%
Susquehanna International Group, LLP16,630$108.0K0.00%
UBS Group AG9,095$59.0K0.00%
Northern Trust Corp13,787$55.0K0.00%
Morgan Stanley3,941$26.0K0.00%
JPMorgan Chase & Co3,000$19.0K0.00%
Wells Fargo & Company2,937$19.0K0.00%
Group One Trading, L.P.412$3.00K0.00%
Credit Suisse AG656$1.00K0.00%
Northwestern Mutual Wealth Management Co102$1.00K0.00%
US Bancorp127$00.00%
Bank of America Corp107$00.00%
Clearstead Advisors, LLC500$00.00%
Royal Bank of Canada516$00.00%
Spark Investment Management LLC29,100$00.00%
Advisor Group Holdings, Inc.1,364$00.00%
OrbiMed Advisors LLC2,718,735––
Transamerica Financial Advisors, Inc.2––

Sold out (1)

Institutions that held Sinovac Biotech Ltd at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of SVA in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Sanders Morris Harris LLC2,000$0